These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 820991)

  • 1. Problems of testing drugs for potential mutagenicity.
    Matter BE
    Mutat Res; 1976 Aug; 38(4):243-58. PubMed ID: 820991
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of mutagenicity and inducibility of DNA single-strand breaks and chromosome aberrations in cultured mouse cells by potent mutagens.
    Tsutsui T; Umeda M; Maizumi H; Saito M
    Gan; 1977 Oct; 68(5):609-17. PubMed ID: 412723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity testing in mammalian cells. II. Validation of multiple drug-resistance markers having practical application for screening potential mutagens.
    Carver JH; Adair GM; Wandres DL
    Mutat Res; 1980 Sep; 72(2):207-30. PubMed ID: 6449664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sister chromatid exchange and chromosome aberration analysis with the use of several carcinogens and noncarcinogens.
    Popescu NC; Turnbull D; DiPaolo JA
    J Natl Cancer Inst; 1977 Jul; 59(1):289-93. PubMed ID: 406414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vivo mutagenicity testing by SCE and micronucleus induction in mouse bone marrow.
    Bauknecht T; Vogel W; Bayer U; Wild D
    Hum Genet; 1977 Mar; 35(3):299-307. PubMed ID: 139356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relevance of a caffeine post-treatment to SCE incidence induced in Chinese hamster cells.
    Popescu NC; Amsbaugh SC; Dipaolo JA
    Mutat Res; 1979 May; 60(3):313-20. PubMed ID: 113671
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of mutagenicity on quiescent and proliferating hamster cell populations.
    Vergara R; Terzi M
    Cell Biol Int Rep; 1980 Mar; 4(3):303-12. PubMed ID: 6769594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actions of 4-nitroquinoline 1-oxide on eucaryotic cells: molecular and cellular studies.
    Ikenaga M; Takebe H
    Carcinog Compr Surv; 1981; 6():65-91. PubMed ID: 6786746
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of chemical carcinogenicity from in vitro genetic toxicity.
    Heddle JA
    Mutagenesis; 1988 Jul; 3(4):287-91. PubMed ID: 3062315
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytogenetic effects of mutagens/carcinogens after activation in a microsomal system in vitro I. Induction of chromosome aberrations and sister chromatid exchanges by diethylnitrosamine (DEN) and dimethylnitrosamine (DMN) in CHO cells in the presence of rat-liver microsomes.
    Natarajan AT; Tates AD; Van Buul PP; Meijers M; De Vogel N
    Mutat Res; 1976 Oct; 37(1):83-90. PubMed ID: 967188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo sister-chromatid exchange: a sensitive measure of DNA damage.
    Nakanishi Y; Schneider EL
    Mutat Res; 1979 May; 60(3):329-37. PubMed ID: 113672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity of nitrosodiethanolamine on Salmonella typhimurium.
    Hesbert A; Lemonnier M; Cavelier C
    Mutat Res; 1979 Nov; 68(3):207-10. PubMed ID: 117355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal effects of carcinogens and non-carcinogens on WI-38 after short term exposures with and without metabolic activation.
    Weinstein D; Katz ML; Kazmer S
    Mutat Res; 1977 Aug; 46(4):297-304. PubMed ID: 408680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on chemical carcinogens. XXIV. Mutagenic potency of alkylated 4-nitroquinoline 1-oxides: its dependence on the rate of metabolic activation.
    Takahashi K; Kohda KH; Kawazoe Y
    Chem Pharm Bull (Tokyo); 1983 Mar; 31(3):959-65. PubMed ID: 6411372
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of changes in the pepsinogen content and the pepsinogen isoenzyme pattern of the pyloric mucosa of the rat stomach by short-term administration of stomach carcinogens.
    Furihata C; Kodama K; Matsushima T
    J Natl Cancer Inst; 1981 Nov; 67(5):1101-4. PubMed ID: 6795378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of various chemical agents on sister chromatid exchanges, chromosome aberrations, and DNA repair in normal and abnormal human lymphoid cell lines.
    Shiraishi Y; Sandberg AA
    J Natl Cancer Inst; 1979 Jan; 62(1):27-35. PubMed ID: 102860
    [No Abstract]   [Full Text] [Related]  

  • 17. "Excision" of bases from DNA methylated by carcinogens in vivo and its possible significance in mutagenesis and carcinogenesis.
    Lawley PD
    Basic Life Sci; 1975; 5A():25-8. PubMed ID: 1103831
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of arginine deprivation upon chromosome aberrations, sces and survival of cho cells treated with mutagenic agents.
    MacRae WD; MacKinnon EA; Stich HF
    Mutat Res; 1979 Oct; 62(3):495-504. PubMed ID: 117351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effect of cysteine on the mutagenic activities of several carcinogens.
    Rosin MP; Stich HF
    Mutat Res; 1978 Aug; 54(1):73-81. PubMed ID: 97526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro chromosome assay using cultured rat-liver cells.
    Dean BJ; Hodson-Walker G
    Mutat Res; 1979 Oct; 64(5):329-37. PubMed ID: 117353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.